Clinically Studies on Treatment of Pulmonary Arterial Hypertension Induced Right Heart Failure
Keywords:
Pulmonary arterial, Hypertension, Dobutamine, Heart failure
Abstract
Objective: to study a clinical treatment of pulmonary arterial hypertension induced right heart failure. Method: A total of 60 cases of pulmonary heart disease right heart failure patients were randomly divided into observation group and control group in which 30 cases for each group. Results: In the observation group of 30 cases, 14 cases produce an effect, 15 cases is effective, 2 cases is invalid and the total effective rate is 96.6%. In the control group of 30 cases, 8 cases produce an effect, 17 cases is effective, 5 cases is invalid and the total effective rate is 83.3%. Conclusion: Dobutamine can alleviate symptoms of heart failure, reduce heart failure patients’ fatality rate and improve prognosis.References
1. Norbert FV, Robert AQ, Leslie AL, et.al. Right ventricular function and failure: Report of a national, lung, and blood institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;14(1):183−189.
2. Wang YZ. Chronic heart failure clinical efficacy of captopril. China Modern Drug Application. 2009,3(13):119−120.
3. LU YX. Theoretical basis evolution of the concept of treatment of heart failure. Clinical Internal Medicine. 2004;21:217−219.
2. Wang YZ. Chronic heart failure clinical efficacy of captopril. China Modern Drug Application. 2009,3(13):119−120.
3. LU YX. Theoretical basis evolution of the concept of treatment of heart failure. Clinical Internal Medicine. 2004;21:217−219.
Published
2015-03-28
Issue
Section
Original Research Article
Copyright (c) 2015 Yudong Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
